George Bers, formerly vice president of systems biology at Beckman Coulter, has left the company, BioCommerce Week has learned.

Bers joined Beckman 2001 as president of the life sciences division.

John Wareham, chairman and CEO of Beckman Coulter, told BCW this week that Bers and the company parted by mutual agreement.

Bruce Wallace, vice president and director of the company’s Systems Biology Business Center, has taken over Bers’ duties, Wareham said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.